New RNA molecules for liver cancer metabolism
Novel biologic RNA molecules to modulate HCC metabolism
This project is creating new, natural-like RNA molecules to help control how liver cancer cells grow and spread.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11145139 on NIH RePORTER |
What this research studies
Liver cancer, especially hepatocellular carcinoma (HCC), is a serious health concern, and we urgently need better treatments. This research focuses on tiny genetic molecules called microRNAs, which play a big role in how cancer cells behave. We are developing a new way to create these microRNAs in a more natural form, similar to how our bodies make them. The goal is to restore important microRNAs that are often missing or reduced in liver cancer cells, which could help slow down or stop tumor growth.
Who could benefit from this research
Good fit: Patients with hepatocellular carcinoma (HCC) who are seeking advanced or novel treatment options might be ideal candidates for future clinical applications of this research.
Not a fit: Patients with other types of cancer or those not specifically affected by the metabolic pathways targeted in HCC may not directly benefit from this particular approach.
Why it matters
Potential benefit: If successful, this work could lead to a new and more effective type of RNA-based therapy for patients with liver cancer.
How similar studies have performed: While the concept of using microRNAs for cancer therapy has been explored, this project introduces a novel bioengineering platform to create more natural and potentially more effective RNA molecules.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Yu, Aiming — University of California at Davis
- Study coordinator: Yu, Aiming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.